Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases.

Front Pediatr · 2023 · PMC10250657 · PMID 37303759

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

did not reach statistical significancep = 0.067so close (0.05 < p ≤ 0.1)

The survival rate of pediatric patients with nonmalignant diseases with mild (grade 1–2) AGVHD was 91.9% and 83.4% for those without AGVHD, although this did not reach statistical significance ( p = 0.067) ( Table 1 and Figure 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.